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Abstract: Introduction: Deep vein thrombosis (DVT) is a major cause of morbidity and mortality in intensive care unit
(ICU) patients despite use of prophylactic anticoagulant therapy. The aim of the present study was to deter-
mine the incidence of DVT among medical and surgical ICU patients. Methods: In this cross sectional study,
patients older than 18 years who were hospitalized in the ICU of Imam Hossein educational Hospital, Tehran,
Iran, for ≥ 2 days, during August 2008 to July 2011 were evaluated regarding DVT incidence. Demographic data,
comorbidities, acute physiology and chronic health evaluation (APACHE) II scores, ICU length of stay, type of
DVT prophylaxis, and patient outcomes were analyzed using SPSS 19. Results: Out of the 1387 reviewed patient
files, 500 (36.04%) patients had been classified as potential DVT cases. DVT occurred in 3.5% of them with the
mean age of 60 ± 18 years (62.5% male) and mortality rate of 27.1%. Significant independent risk factors of DVT
incidence were age (p = 0.02) and length of ICU stay (p = 0.01). Conclusion: The results of this study showed the
3.5% incidence of DVT in ICU admitted patients. Longer ICU stay and older age were independent risk factors
of DVT development.
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1. Introduction
Venous thromboembolism (VTE) is the third most com-
mon cardiovascular disorder after myocardial infarction and
stroke (1). The rate of morbidity and mortality associated
with thromboembolic events is high, with 28-day fatality
rates reported to be 9% for deep vein thrombosis (DVT) and
15% for pulmonary embolism (PE) (2). The causes of DVT
may be acquired, inherited or a combination of both (3). The
diagnosis and treatment of DVT are challenging and expen-
sive (3). DVT can complicate the course of a disease, but
may also be encountered in the absence of precipitating fac-
tors. While long-term morbidity due to post-thrombotic syn-
drome is common, and can be substantial, the major com-
plication is embolization of the thrombus to the lung (4). Ex-
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tensive epidemiological studies of patients with thromboem-
bolism have identified several factors that enhance the risk
of DVT development. These include surgery, age, gender,
heart failure, history of previous thromboembolism, direct
trauma to the leg, use of oral contraceptives, and limb weak-
ness (3, 5). The majority of intensive care unit (ICU) pa-
tients have one or more risk factors for DVT (3). These pa-
tients are further predisposed to DVT during their ICU stay
due to prolonged immobilization, sepsis, and vascular injury
from indwelling central venous catheters or other invasive
interventions (6). The incidence of reported DVT is likely to
vary across populations, based on baseline characteristics of
patients, post-ICU admission events and patient condition,
clinical suspicion for VTE, the scheduling and methods of
VTE screening, and prophylactic interventions. A retrospec-
tive study on ICU patients undergoing color-flow Doppler
sonography for DVT screening has shown an estimated inci-
dence of 33% (5). Cross-sectional studies of medical and sur-
gical ICU patients have shown that approximately 10% have
proximal DVT on admission to the ICU (7, 8). One study re-
ports a VTE rate of 9 per 10,000 hospital admissions in an Ira-
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nian population (9). Based on the above mentioned, the aim
of the present study was to determine the incidence of DVT
among medical and surgical ICU patients.
2. Methods
2.1. Study design and setting
In this retrospective cross sectional study, patients older than
18 years who were hospitalized in ICU of Imam Hossein ed-
ucational Hospital, Tehran, Iran, for ≥ 2 days were evalu-
ated. The study was conducted in accordance with the prin-
ciples of the 18th world medical assembly (Helsinki, 1964)
and all subsequent amendments. The study received ethi-
cal approval from Shahid Beheshti University of Medical Sci-
ences.
2.2. Participants
All consecutive patients admitted to the ICU for the first time,
between August 2008 and July 2011, were considered for in-
clusion in the study. Patients were excluded if they either
had a documented DVT/PE before or within 48 hours of ICU
admission or died or had missing or incomplete data dur-
ing that time period. In this 21 bed ICU, a large variety of
medical, surgical, orthopedics, neurosurgical, trauma, car-
diac surgery and obstetrics and gynecology patients are man-
aged. The ICU care is directed and run by trained intensivists
in a semi-closed fashion with an average patient length of
stay of 8 days.
2.3. Data collection
We collected data from patients electronic medical records
and a regional ICU database. For each patient with clinically
and Doppler proven DVT, key demographic and clinical char-
acteristics including age, sex, diagnosis on admission, Acute
Physiology and Chronic Health Evaluation II (APACHE II)
score, VTE prophylaxis regimen, duration of mechanical ven-
tilation, length of ICU stay and patient’s outcome (discharge
or death) were collected. To provide a uniform and unbi-
ased assessment of Doppler proven DVT, one research asso-
ciate, who was a vascular surgeon, performed the Doppler
examination for all patients potentially having DVT and was
blinded to the patients’ history and clinical status. All clinical
decisions were made at the discretion of the ICU team. Po-
tentially having DVT was defined as International ClassiFica-
tion of Diseases, 9th Revision, Clinical ModiFication (ICD-9-
CM) codes (453.40, 453.41, 453.42, 453.80, and 453.90).
2.4. Statistical Analysis
All statistical analyses were performed using SPSS version 19.
Continuous data were expressed as mean and standard de-
viation for normally distributed data or median and inter-
quartile range for non-normally distributed data. Categori-
cal data were summarized as counts and percentages. Con-
tinuous data were contrasted between groups using the t-test
or rank test as appropriate. Categorical data were contrasted
using the chi-squared test. Multiple logistic regressions were
used to identify independent risk factors associated with the
presence of DVT. A p value less than 0.05 was considered sta-
tistically significant.
3. Results:
Out of the 1387 reviewed patient files during the study pe-
riod, 500 (36.04%) patients had been diagnosed as poten-
tially having DVT and underwent venous color Doppler ul-
trasonography. Table 1 shows the baseline characteristics of
patients. Based on the results of ultrasonography, 48 (3.5%)
cases had DVT (62.5 % male). Their mean age was 60 ± 18
years and they had the mean APACHE II score of 16.3±5.1 and
ICU mortality rate of 27.1%. Table 2 summarized character-
istics of these patients. None of the patients had bleeding or
treatment-related complications during the study. Univari-
ate analysis showed significant correlation of age (p = 0.02)
and length of ICU stay with incidence of DVT (p = 0.01) (Table
2). Based on multivariate analysis, only a longer ICU stay sig-
nificantly associated with DVT incidence (OR: 1.07 per each
day of ICU stay; 95% CI: 1.03-1.22; p value, 0.01).
4. Discussion:
The results of the present study revealed 3.5 % incidence
of DVT in ICU admitted patients of Imam Hossein Hospi-
tal. DVT is difficult to diagnose because of the poor sensitiv-
ity and specificity of clinical symptoms and signs (10). DVT
usually originates in the calf veins where the risk of subse-
quent complications is low. The classic symptoms and signs
are due to venous obstruction and an inflammatory response
in the affected area. However, the majority of DVT cases re-
main clinically silent (11). The diagnostic gold standard tools
for DVT and PE were venography and pulmonary angiogra-
phy, both of which are invasive and costly. Doppler sonog-
raphy examination has emerged as the noninvasive imaging
method of choice for evaluation of DVT. It has the added abil-
ity of being able to visualize other pathologies mimicking ve-
nous obstruction (3). The incidence of DVT in this survey is
lower than that reported in Chinese (19%) and Caucasian (28-
32%) medical ICU patients not receiving prophylaxis (12-14).
Many factors could contribute to this relatively low incidence
in comparison to other countries (15). There is an association
between age and incidence of DVT (16). The Iranian pop-
ulation, like other Middle Eastern countries, is very young;
while about 43% of the Western population are 40 years and
above, only 18% of Iranians are in this age range (17). How-
ever, with increasing age of the Iranian population, DVT will
probably become a growing public health problem. On the
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Table 1: Baseline characteristics of studied patients
Parameters N (%) APACHE II DVT n (%) Incidence Rate*
Age (year)
≤40 492(35.47) 13.7 ± 4.7 10 (2.03) 1.64
46 - 65 391(28.19) 14.4 ± 5 16(4.09) 3.07
≥66 504(36.34) 18.9 ± 4.2 22(4.37) 3.04
Sex
Male 807(58.18) 17 ± 5.4 30(3.72) 2.84
Female 580(41.82) 15.2 ± 4.5 18(3.10) 2.26
ICU stay (day)
âL’d’7 722(52.05) 15.6 ± 4.7 8(1.11) 2.45
8-28 500(36.05) 16.4 ± 5.9 24(4.80) 3.33
âL’ě29 165(11.90) 16.5 ± 4.2 16(9.70) 1.99
Year
2008 263(18.96) 13.1 ± 6.5 7(2.66) 1.92
2009 476(34.32) 16.6 ± 4.5 21(4.41) 3.08
2010 514(37.06) 16.1 ± 5.4 14(2.72) 2.15
2011 134(9.66) 19.5 ± 3 6(4.48) 3.83
* Rate per 1000 person days; APACHE II: Acute Physiology and Chronic Health Evaluation II; DVT: deep vein thrombosis;
ICU: intensive care unit; data were presented as mean Âś standard deviation or number and percentage.
Table 2: Characteristics of cases potentially having deep vein thrombosis (DVT) among intensive care unit (ICU) admitted patients
Variable
Color Doppler ultrasound for DVT P Value
Negative (n=452) Positive (n=48)
Age (year) 51 ± 19 60 ± 18 0.02
Gender (male) 259 (57.3%) 30 (62.5%) 0.6
APACHE II 14.2 ± 5.4 16.1 ± 4.8 0.2
ICU stay (Day) 21 ± 31 30 ± 30 0.01
Diagnoses
Acute Hemorrhagic Stroke 82 (18.1%) 10 (20.8%) 0.7
Multiple Trauma 124 (27.5 %) 12 (25%) 0.8
Respiratory Distress 49 (10.8%) 6 (12.5%) 0.7
Acute Abdomen 45 (9.9%) 5 (10.4%) 0.8
Acute Ischemic Stroke 48 (10.6 %) 5 (10.4%) 0.9
Cancer 23 (5.1%) 3 (6.2%) 0.7
Sepsis 36 (8%) 3 (6.3%) 0.7
Loss of consciousness 24 (5.3%) 1 (2.1%) 0.6
Others 21(4.7%) 3 (6.2%) 0.7
Type of DVT Prophylaxis
LMWH 137 (30.3%) 19 (39.6%) 0.5
Heparin 191 (42.2%) 12 (25%) 0.05
IPC and GCS 124 (27.5%) 17 (35.4%) 0.5
ICU Mortality 88 (19.5%) 13 (27.1%) 0.5
APACHE II: Acute Physiology and Chronic Health Evaluation II; LMWH: low molecular weight heparin;
IPC: Intermittent Pneumatic Compression; GCS: graduated compression stockings; DVT: deep vein thrombosis,
ICU: intensive care unit; data were presented as mean ± standard deviation or number and percentage.
other hand, it is likely that increased physician awareness
of DVT risk factors and increased utilization of noninvasive
imaging have led to a higher diagnosis rate (18). DVT inci-
dence increases rapidly with age in an apparently linear form
suggesting a constant incidence and cumulative prevalence,
especially in those older than 65 years (1). Old age is one of
the risk factors in patients with DVT (16). The mean age of
patients was almost 60 years, which was within the age range
of people prone to venous thromboembolism (over 40 years
of age) (1). In addition, consistent with previous studies,
which have shown DVT to be more common among men (9),
approximately 62.5% of our DVT patients were male. How-
ever, length of ICU stay was the most significant factor as-
sociated with the presence of DVT. The interpretation is that
in many patients, DVT developed after they were admitted
to the ICU and the risk of DVT increased with a longer ICU
stay. The mean APACHE II score was 16.3 ± 5.1 and ICU
mortality rate was 27.1% (13 in the 48 patients with DVT).
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The in-hospital mortality rate, observed in this study, ap-
pears similar to those reported from other studies in major
academic health centers (2, 19). It is not clear whether this
increase in fatality should be attributed to the accompanying
risk factors, or to the severity of DVT (proximal), most likely
both play an important role (20). We suggest that prophy-
laxis be administered to those with three or more risk factors.
The mortality rate of DVT has a strong association with other
risk factors such as, cardiovascular disease, cancer, states fol-
lowing surgery or trauma (2, 21). Evidence-based consen-
sus guidelines for VTE prophylaxis have been available since
a long time ago (22). The American College of chest physi-
cians (ACCP) guidelines recommend prophylaxis for patients
at moderate-to-high risk of VTE, using mechanical prophy-
laxis and/or pharmacological prophylaxis (19, 23). Despite
the recommendations of international guidelines, physicians
often do not prescribe prophylaxis therapy in high-risk situ-
ations (24). Means to improve DVT prophylaxis should in-
clude increasing physicians awareness through training and
the implementation of procedures to assess DVT risk during
hospitalization, along with the application of evidence-based
guidelines for DVT prophylaxis and treatment in both med-
ical and surgical patients (23). There are no local guidelines
for DVT prevention in Iran. Considering that DVT is a serious
clinical condition that may lead to patient death, we recom-
mend the assessment of DVT risk (using a risk model assess-
ment form, locally adapted) for all hospitalized patients on
admission and during hospitalization.
5. Limitations:
The main limitation of our study is its retrospective and sin-
gle center design. Prospective multicenter studies are recom-
mended.
6. Conclusion:
The results of this study showed the 3.5% incidence of DVT
in ICU admitted patients of Imam Hossein Hospital, Tehran,
Iran. Longer ICU stay and older age were independent risk
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